复发前庭神经鞘瘤初次治疗后的挽救手术:手术结局与无进展生存的荟萃分析
汇总全切除率为0.71(95%CI:0.46-0.87),术后 facial nerve 功能恶化发生率为43%(95%CI:0.29-0.58),脑脊液漏为最常见并发症(11%,95%CI:0.05-0.21)。作者结论为再次显微手术肿瘤控制良好,但面神经恶化等风险高于初次手术,现有证据受小样本和回顾性设计限制。
要点
- 复发前庭神经鞘瘤再次显微手术汇总全切除率为0.71(95%CI:0.46-0.87)。
- 术后 facial nerve 功能恶化发生率为43%(95%CI:0.29-0.58)。
- 脑脊液漏为最常见并发症,发生率为11%(95%CI:0.05-0.21)。
核心结论
- 复发前庭神经鞘瘤再次显微手术可获得良好的肿瘤控制,但 facial nerve 恶化及其他并发症风险高于初次手术。
主要发现
- 汇总全切除率为0.71(95%CI:0.46-0.87)。
- 4项研究共49例报告无进展生存,未见肿瘤复发(汇总比例=1.00)。
- 术后 facial nerve 功能恶化发生率为43%(95%CI:0.29-0.58)。
- 脑脊液漏为最常见并发症,发生率为11%(95%CI:0.05-0.21)。
- 多数研究间异质性为低至中度(I²=0-38.6%)。
局限性
- 现有证据受小样本队列和回顾性设计限制。
- 作者指出需要标准化报告和前瞻性多中心研究以改善该罕见且具挑战性疾病的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vestibular schwannomas (VS) are benign tumors of the eighth cranial nerve. While gross total resection (GTR) is often achieved in primary surgery, recurrence remains a therapeutic challenge. Repeat microsurgery is a key treatment option, but evidence is limited and inconsistently reported. This study systematically synthesizes current data on outcomes after repeat microsurgical resection for recurrent VS. METHODS: A systematic PubMed search identified studies reporting outcomes of repeat microsurgery for recurrent VS. Extracted data included patient characteristics, GTR rate, progression-free survival (PFS), facial nerve function (House-Brackmann scale), hearing preservation, postoperative complications, and hydrocephalus or shunt dependency. Pooled analyses using random-effects models estimated summary proportions across studies. RESULTS: Ten studies including 359 patients met inclusion criteria. The pooled GTR rate was 0.71 (95% CI: 0.46-0.87). Four studies (49 patients) reported PFS, with no tumor recurrences (pooled proportion = 1.00). Postoperative facial nerve deterioration occurred in 43% (95% CI: 0.29-0.58). Cerebrospinal fluid (CSF) leakage was the most frequent complication (11% (95% CI: 0.05-0.21)). Between-study heterogeneity was low to moderate in most of the studies (I² = 0-38.6%). CONCLUSIONS: Repeat microsurgery for recurrent VS provides good tumor control but carries higher risks of facial nerve deterioration and other complications compared with primary surgery. Current evidence is limited by small cohorts and retrospective designs. Standardized reporting and prospective multicenter studies are required to improve treatment strategies for this rare and challenging condition.
引用
- Haddad L, Arlt F, Güresir E, et al. Salvage surgery following primary treatment in recurrent vestibular schwannoma: surgical outcomes and progression-free survival- a meta-analysis. J Neurooncol. 2026. PMID: 42215714. doi:10.1007/s11060-026-05629-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。